During the H1N1 outbreak in 2009, vaccines only became available in large quantities after the peak of human infections. This was a learning experience for vaccination companies.
The availability of vaccines during the 2009 H1N1 outbreak was delayed due to the peak of human infections. This delay prompted vaccine manufacturers to learn from their mistakes and improve future production processes.